Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Ghali

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Canadian Journal of Surgery. Journal Canadien De Chirurgie|March 30, 2011
Association of preoperative parameters with postoperative mortality and long-term survival after liver transplantationDionisios Vrochides, Mazzen Hassanain, Jeffrey Barkun, et al.
AIDS (London, England)|October 26, 2019
Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patientsGiada Sebastiani, Sahar Saeed, Bertrand Lebouche, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 15, 2013
Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centresStephen E Congly, Philip Wong, Said A Al-Busafi, et al.
Journal of Hepatology|May 22, 2017
Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosisThomas Pembroke, Marc Deschenes, Bertrand Lebouché, et al.
The Journal of Infectious Diseases|April 7, 2020
Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus InfectionThomas Krahn, Myriam Martel, Ruth Sapir-Pichhadze, et al.
Journal of Virus Eradication|October 24, 2017
The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure researchVikram Mehraj, Peter Ghali, Rayoun Ramendra, et al.
Journal of Hepatology|May 19, 2009
Evaluation of VCH-759 monotherapy in hepatitis C infectionCurtis Cooper, Eric J Lawitz, Peter Ghali, et al.
Inflammatory Bowel Diseases|June 12, 2018
Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient ElastographyChiara Saroli Palumbo, Sophie Restellini, Che-Yung Chao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 2, 2017
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trialsEdward Tam, Anne F Luetkemeyer, Parvez S Mantry, et al.
Transplantation|March 24, 2012
Clostridium difficile colitis: increasing incidence, risk factors, and outcomes in solid organ transplant recipientsMarylise Boutros, Maha Al-Shaibi, Gabriel Chan, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Canadian Journal of Surgery. Journal Canadien De Chirurgie|March 30, 2011
Association of preoperative parameters with postoperative mortality and long-term survival after liver transplantationDionisios Vrochides, Mazzen Hassanain, Jeffrey Barkun, et al.
AIDS (London, England)|October 26, 2019
Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patientsGiada Sebastiani, Sahar Saeed, Bertrand Lebouche, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 15, 2013
Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centresStephen E Congly, Philip Wong, Said A Al-Busafi, et al.
Journal of Hepatology|May 22, 2017
Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosisThomas Pembroke, Marc Deschenes, Bertrand Lebouché, et al.
The Journal of Infectious Diseases|April 7, 2020
Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus InfectionThomas Krahn, Myriam Martel, Ruth Sapir-Pichhadze, et al.
Journal of Virus Eradication|October 24, 2017
The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure researchVikram Mehraj, Peter Ghali, Rayoun Ramendra, et al.
Journal of Hepatology|May 19, 2009
Evaluation of VCH-759 monotherapy in hepatitis C infectionCurtis Cooper, Eric J Lawitz, Peter Ghali, et al.
Inflammatory Bowel Diseases|June 12, 2018
Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient ElastographyChiara Saroli Palumbo, Sophie Restellini, Che-Yung Chao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 2, 2017
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trialsEdward Tam, Anne F Luetkemeyer, Parvez S Mantry, et al.
Transplantation|March 24, 2012
Clostridium difficile colitis: increasing incidence, risk factors, and outcomes in solid organ transplant recipientsMarylise Boutros, Maha Al-Shaibi, Gabriel Chan, et al.
Pageof 6